Literature DB >> 7515611

Purification and characterization of the constitutive nitric oxide synthase from human placenta.

E P Garvey1, J V Tuttle, K Covington, B M Merrill, E R Wood, S A Baylis, I G Charles.   

Abstract

Human endothelial nitric oxide synthase (NOS) mRNA was detected in human placenta. In contrast, mRNAs for human neuronal NOS or for human inducible NOS were not detected in placenta. Subsequently, NOS was purified over 3800-fold from placental extract to greater than 80% homogeneity. A single band with an apparent molecular weight of 135 kDa was identified by [125I] calmodulin binding to proteins in a sodium dodecyl sulfate-polyacrylamide gel, which is consistent with the predicted size of the endothelial NOS. Furthermore, the sequence of eight internal peptides derived from this 135-kDa protein was identical to the published sequence of human endothelial NOS. As has been shown for all constitutive NOS isozymes, the purified NOS was absolutely dependent on calcium and calmodulin. NOS was also purified from human umbilical vein endothelial cells and, on the basis of similar kinetic parameters and dependence upon calcium and calmodulin, appeared to be the same as the purified placental NOS. Together, these data indicate that the placental NOS is the constitutive NOS isozyme from endothelial tissue.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515611     DOI: 10.1006/abbi.1994.1232

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  19 in total

1.  Modulation of endothelial nitric oxide synthase by fibronectin.

Authors:  R I Viji; V B Sameer Kumar; M S Kiran; P R Sudhakaran
Journal:  Mol Cell Biochem       Date:  2008-12-04       Impact factor: 3.396

2.  Benzothiophene Selective Estrogen Receptor Modulators Provide Neuroprotection by a novel GPR30-dependent Mechanism.

Authors:  Ramy Abdelhamid; Jia Luo; Lawren Vandevrede; Indraneel Kundu; Bradley Michalsen; Vladislav A Litosh; Isaac T Schiefer; Teshome Gherezghiher; Ping Yao; Zhihui Qin; Gregory R J Thatcher
Journal:  ACS Chem Neurosci       Date:  2011-05-18       Impact factor: 4.418

Review 3.  The role of asymmetric and symmetric dimethylarginines in renal disease.

Authors:  Edzard Schwedhelm; Rainer H Böger
Journal:  Nat Rev Nephrol       Date:  2011-03-29       Impact factor: 28.314

4.  Expression of the calcium-independent cytokine-inducible (iNOS) isoform of nitric oxide synthase in rat placenta.

Authors:  M Casado; M J D-iaz-Guerra; J Rodrigo; A P Fernández; L Boscá; P Martín-Sanz
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

5.  Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies.

Authors:  R A Rutherford; A McCarthy; M H Sullivan; M G Elder; J M Polak; J Wharton
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

6.  Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase.

Authors:  R J MacAllister; H Parry; M Kimoto; T Ogawa; R J Russell; H Hodson; G S Whitley; P Vallance
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

7.  Adenosine A2A receptor activation attenuates tubuloglomerular feedback responses by stimulation of endothelial nitric oxide synthase.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Welch
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-24

8.  Decreased contraction induced by endothelium-derived contracting factor in prolonged treatment of rat renal artery with endoplasmic reticulum stress inducer.

Authors:  Makoto Ando; Takayuki Matsumoto; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-04       Impact factor: 3.000

9.  Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice.

Authors:  Yong Chen; Michael K Boettger; Andreas Reif; Angelika Schmitt; Nurcan Uçeyler; Claudia Sommer
Journal:  Mol Pain       Date:  2010-03-02       Impact factor: 3.395

10.  Endothelial nitric oxide synthase immunoreactivity in early gestation and in trophoblastic disease.

Authors:  I Ariel; A Hochberg; M Shochina
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.